IRTG PhD Positions

Key Research Areas:

• Genomic instability driven by p53 deficiency
• Metabolic shifts and stress-induced genomic instability
• Heterogeneity in KRAS-driven tumors
• In silico technologies for evolutionary trajectory reconstruction and AI-based tumor analysis

What We Offer:

• A structured PhD program with dual mentorship from leading scientists in Germany and Korea
• Opportunities for international collaboration and research exchange
• Access to state-of-the-art facilities and technologies
• Comprehensive training in both basic and translational research methodologies
• A stimulating environment that encourages scientific excellence and career development

Eligibility Criteria:

• A Master’s degree in molecular biology, biomedicine, oncology, bioinformatics, or a related field
• A strong academic record and research experience in relevant area
• Excellent communication skills and the ability to work collaboratively in an international setting
• Demonstrated interest in cancer research, particularly lung cancer
• Proficiency in English (both written and spoken)

Application Requirements:

• A detailed CV including academic background, research experience, and publications
• A motivation letter describing why you would like to join the IRTG program and your research interest
• Academic transcripts and degree certificates
• Contact details of at least two academic referees

How to Apply:

Interested candidates should submit their applications electronically to https://www.cs-irtg.com. The PhD program begins on April 1st, 2025, but applications can be considered until later for highly qualified applicants. For further information about the program and application process, please visit our website: www.CS-IRTG.com.

Join us in advancing the frontiers of lung cancer research and make a significant impact on global health through innovative science and international collaboration.

Contact Information:

Dr. Sonja Meemboor ([email protected])